You Need To Know The Efficacy Of Kedi QINGHAO CAPSULE Against Malaria Attacks?

Kedi Qinghao Capsule is a tested and trusted medication produced by kedi healthcare industries to treat any form of malaria, especially resistant malaria. Malaria infection is a disease caused by plasmodium species. The spread of this parasite is through the bites of infected female Anopheles mosquitoes to humans.

People who are infected with malaria usually feel very sick with a symptom of high fever and shaking chills. Malaria parasite infestation is common in tropical and subtropical countries, while the disease is uncommon in temperate countries.

People who lived in the tropics like in sub-Saharan Africa contracted malaria at a young age. Researchers believe that when these people live with parasites in their blood for a long time, it helps them to build immune tolerance to those strains of the parasite.

The recurrence in patients with malaria can be caused by Reinfection from a new mosquito bite with a patient that has already been treated for malaria can cause recurrence, recrudescence, or relapse. You can see relapse occurring in P. vivax and P. ovale infections through the activation of hypnozoites inside the human liver.

Kedi Qinghao Capsule

Here are the symptoms of resistant malaria:

  • Feverish conditions
  • Having Chills.
  • Having a general feeling of discomfort.
  • Headache
  • Diarrhea
  • Muscle or joint pain
  • Nausea and vomiting.
  • Abdominal pain.

What causes resistance to malaria? The causes of malaria parasite resistance arise from several factors, some of which include the overuse of antimalarial drugs for prophylaxis, and inadequate or incomplete treatments during previous malaria infections. Other causes might be because of a high level of parasite adaptability at the genetic and metabolic levels.

It is thought that people with sickle cell trait (genotype HbAS) are not prone to malaria attacks. Some schools of thought believed that they have resistance to malaria parasite disease because of their sickle-shaped cells but the precise mechanism remains unknown.

Product Benefits of Kedi Qinghao Capsule: It is used for the treatment of all forms of Malaria especially those caused by Plasmodium falciparum and anti-drug resistant Malaria.

Active Ingredients:

  1. Dihydroartemisinin – 40 mg
  2. Piperaquine phosphate 320 mg

1.  Health benefits of Dihydroartemisinin:

Dihydroartemisinin, also referred to as dihydroqinghaosu, artenimol, or DHA, is an antimalarial drug. The active metabolite of all artemisinin compounds (including artemisinin, artesunate, artemether, etc.) is dihydroartemisinin, which is also sold as a separate medication.

It is a frequently utilized intermediary in the manufacture of other artemisinin-derived antimalarial drugs. It is a semi-synthetic derivative of artemisinin. Dihydroartemisinin appears to function in part by producing free radicals, which later cause damage to the membranes of various parasite species. This action affects all stages of malaria parasites resulting in rapid death.

2.  Health Benefits of Piperaquine phosphate: Piperaquine is an antimalarial medicine, and can be used in a combination with other products to combat any form of malaria, both in adults and children.

Do you know that the World Health Organization (WHO) recommends Artemisinin‐based Combination Therapy (ACT) for treating uncomplicated Plasmodium falciparum malaria?

Piperaquine phosphate is an effective anti-malarial drug treatment that reduces malaria transmission, and that is why Kedi healthcare industries combined the two ingredients (Piperaquine phosphate & Dihydroartemisinin) to produce Qinghao Capsule.

Kedi Qinghao Capsule has the special benefit of eradicating the malaria parasite both in the erythrocytic and exo-erythrocytic cycle without any side effects. It is not toxic to the body, and the assimilation to the bloodstream is fast, thus giving quick and permanent relief. It can also be used in combination with other kedi herbal drugs. Use Kedi Qinghao Capsule and also recommend it to others.

Leave a Reply